Brief: Sight Sciences Announces $34 Mln Patent Infringement Verdict Against Alcon And Hydrus Microstent
29/04/2024 13:18
April 29 (Reuters) - Sight Sciences Inc SGHT.O :
* SIGHT SCIENCES ANNOUNCES SUCCESSFUL $34 MILLION PATENT
INFRINGEMENT VERDICT AGAINST ALCON AND ITS HYDRUS MICROSTENT FOR
MICROINVASIVE GLAUCOMA SURGERY
Source text for Eikon: ID:nGNX7FkmwZ
Further company coverage: SGHT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sight Sciences
See all newsSight Sciences raises FY 2026 revenue outlook
Brief: Sight Sciences Q1 Revenue USD 19.7 Million Vs. IBES Estimate USD 18.5 Million
Brief: Sight Sciences U.S. District Court Issued Order On Post-Trial Motions In Patent Infringement Case Against Alcon Originally Filed On Sep 16, 2021
Sight Sciences Q4 revenue rises 7%
Brief: Sight Sciences Announces Preliminary, Unaudited Fourth Quarter And Full Year 2025 Financial Highlights